Table 1. Reason why DFX was discontinued.

Adverse event	Number of patients
Generally non-specifically unwell	2
Severe diarrhea	1
Pregnancy	1
Fluctuating high transaminases (both hepatitis C positive)	2
Not biochemically effective at reducing serum ferritin with subsequent conversion to DFO & DFP after 18 months therapy	3
Adverse effects on renal function	7